Rem Koning
Kiki Freedman
Nada Hanafi MSc, MPH
Wei Escala
Wei Escala is the founder and CEO of Eggschain, a healthcare technology company built at the intersection of reproductive medicine, technology innovation, scientific research and humanity. A thought leader in the health tech, family building and cryogenic preservation industries, Ms. Escala holds the patent for the first blockchain-integrated inventory management and chain of custody technology for tracking bio specimens, including sperm, eggs, embryos, DNA, RNA, genome, stem cell, tissues and organs, and other genetic material. As Eggschain CEO, she has built an all-star team of collaborators comprising technologists, business leaders, physicians and scientists, with a focus on continuing to develop game-changing innovation for patients, doctors, clinics and labs through the Eggschain platform.
A software engineer by training, Ms. Escala has built a career across the organizational spectrum, from Marketing and Brand Management to Software Leadership. Prior to Eggschain, Ms. Escala held executive roles at such Fortune 500 companies as Procter & Gamble, Frito Lay, Valvoline and Kraft Foods, where she managed P&Ls of up to 300 million USD. She is passionate about women’s health and the opportunity to enable security, transparency and peace of mind for people and families, enabling better decision making and helping advance humanity.
Derek Sham
Derek has 15+ years experience in medical devices R&D and commercialization in urology, gynecology, gastroenterology and cardiology. He is a General Manager with a successful PE-backed exit in urological diagnostics in 2016 and was inspired to launch Cosm as a result of his grandmother's health.
Kat Holmes
Kostas Papadopoulos
Betsy Bluestone
Ezekiel Fink
Ezekiel Fink M.D. is a Harvard trained physician with triple board certifications in neurology, pain medicine, and brain injury medicine. Dr. Fink joined Houston Methodist in 2014, designed and investigated numerous industry clinical trials, and was recognized for excellence in research by the Office of Research Protections in 2019. Today Dr. Fink’s positions include being a key opinion leader in matters relating to opioids for the Centers for Disease Control and Prevention and the National Safety Council, an Assistant Clinical Professor at UCLA, and Medical Director of Pain for the Houston Methodist hospital system.
